Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

Abstract:

:To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty patients having received an autologous-SCT fulfilled the criteria to be included, 138 patients without an HLA-identical sibling donor and 122 patients with a donor. After a median follow-up of 77 months, complete remission, progression-free survival (PFS), and overall survival were not significantly different between the 2 groups. PFS at 6 years was 28% for patients with a donor versus 22% for patients without a donor (P = .19) and overall survival at 6 years from high-dose melphalan was 55%, irrespective of having a donor (P = .68). Cumulative incidence of nonrelapse mortality at 6 years after autologous-SCT was 16% in the donor group versus 3% in the no-donor group (P < .001). However, PFS was significantly prolonged in the 99 patients who actually proceeded to allo-SCT compared with the 115 patients who continued maintenance or received a second high-dose melphalan, but the difference did not translate into a prolonged survival benefit. These results do not support a general application of allo-SCT in all myeloma patients as part of first-line therapy.

journal_name

Blood

journal_title

Blood

authors

Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

doi

10.1182/blood-2011-11-393801

subject

Has Abstract

pub_date

2012-06-28 00:00:00

pages

6219-25; quiz 6399

issue

26

eissn

0006-4971

issn

1528-0020

pii

blood-2011-11-393801

journal_volume

119

pub_type

杂志文章,多中心研究,随机对照试验

相关文献

BLOOD文献大全
  • Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter.

    abstract::Hemophilia B Leyden is an X chromosome-linked bleeding disorder characterized by an altered developmental expression of blood coagulation factor IX. This form of hemophilia B has been found to be associated with a variety of single point mutations in the factor IX promoter region. We now describe a novel point mutatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reijnen MJ,Peerlinck K,Maasdam D,Bertina RM,Reitsma PH

    更新日期:1993-07-01 00:00:00

  • Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.

    abstract::The expression of tumor-associated antigens (TAAs) might play a critical role in the control of minimal residual disease (MRD) in acute myeloid leukemia (AML), and therefore might be associated with clinical outcome in AML. In a DNA microarray analysis of 116 AML samples, we found a significant correlation between hig...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-01-023127

    authors: Greiner J,Schmitt M,Li L,Giannopoulos K,Bosch K,Schmitt A,Dohner K,Schlenk RF,Pollack JR,Dohner H,Bullinger L

    更新日期:2006-12-15 00:00:00

  • Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

    abstract::Serum cytokines and chemokines may reflect tumor biology and host response in follicular lymphoma (FL). To determine whether the addition of these biological factors may further refine prognostication, 30 cytokines and chemokines were measured in pretreatment serum specimens from newly diagnosed FL patients (n = 209) ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2014-06-583369

    authors: Mir MA,Maurer MJ,Ziesmer SC,Slager SL,Habermann T,Macon WR,Link BK,Syrbu S,Witzig T,Friedberg JW,Press O,LeBlanc M,Cerhan JR,Novak A,Ansell SM

    更新日期:2015-02-05 00:00:00

  • Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

    abstract::Activated factor XII (FXIIa) has plasminogen activator capacity but its relative contribution to fibrinolysis is considered marginal compared with urokinase and tissue plasminogen activator. Polyphosphate (polyP) is released from activated platelets and mediates FXII activation. Here, we investigate the contribution o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-10-673285

    authors: Mitchell JL,Lionikiene AS,Georgiev G,Klemmer A,Brain C,Kim PY,Mutch NJ

    更新日期:2016-12-15 00:00:00

  • Oxidative red blood cell membrane injury in the pathophysiology of severe mouse beta-thalassemia.

    abstract::In severe human beta-thalassemia, the pathophysiology relates to accumulation of excess alpha-globin chains at the membrane. One hypothesis is that membrane-associated alpha-globin by virtue of it's iron or hemichromes produces oxidation of adjacent membrane proteins. The availability of a mouse model of severe beta-t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Advani R,Rubin E,Mohandas N,Schrier SL

    更新日期:1992-02-15 00:00:00

  • How I manage the toxicities of myeloma drugs.

    abstract::The treatment of multiple myeloma is considered a continuously evolving paradigm as a result of the growing availability of new and highly effective drugs, including first- and second-generation proteasome inhibitors, immunomodulatory agents, and monoclonal antibodies. Clinical trials advocate long-term rather than sh...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-01-725705

    authors: Delforge M,Ludwig H

    更新日期:2017-04-27 00:00:00

  • The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients.

    abstract::Fanconi anemia (FA) is an autosomal recessive disease characterized by congenital anomalies, aplastic anemia, and a susceptibility to leukemia. There are at least 8 complementation groups (A through H). Extensive analyses of the FA group C gene FANCC in Western countries revealed that 10% to 15% of FA patients have mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Futaki M,Yamashita T,Yagasaki H,Toda T,Yabe M,Kato S,Asano S,Nakahata T

    更新日期:2000-02-15 00:00:00

  • Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm.

    abstract::Epithelial mesenchymal transitions are a remarkable example of cellular plasticity. These transitions are the hallmark of embryo development, are pivotal in cancer progression, and seem to occur infrequently in adult organisms. The reduced incidence of transitions in the adult could result from restrictive functions o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2003-08-2807

    authors: Prindull G,Zipori D

    更新日期:2004-04-15 00:00:00

  • Intermediate syndrome of platelet dysfunction.

    abstract::We studied eight patients with intermittent bleeding episodes usually following trauma and associated with the ingestion of medicine known to interfere with platelet function. All patients had a normal or minimally prolonged baseline bleeding time. All had a normal platelet count, glass bead retention test, and platel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Czapek EE,Deykin D,Salzman E,Lian EC,Hellerstein LJ,Rosoff CB

    更新日期:1978-07-01 00:00:00

  • Extracellular ubiquitin inhibits the TNF-alpha response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness.

    abstract::Ubiquitin is suggested to play a key role in essential intracellular functions, such as heat shock response, protein breakdown, and regulation of immune responses. Ubiquitin has also been detected in the extracellular space, but the function and biologic significance is unclear. We describe a new function of extracell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0918

    authors: Majetschak M,Krehmeier U,Bardenheuer M,Denz C,Quintel M,Voggenreiter G,Obertacke U

    更新日期:2003-03-01 00:00:00

  • Characterization of murine bone marrow and spleen-derived stromal cells: analysis of leukocyte marker and growth factor mRNA transcript levels.

    abstract::Stromal cells are believed to regulate lympho-hematopoiesis through direct cell-cell interactions and the release of growth factors. Many questions remain, however, about their lineage derivation and functional heterogeneity. We previously prepared a panel of stromal cell lines from murine spleen and bone marrow and c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gimble JM,Pietrangeli C,Henley A,Dorheim MA,Silver J,Namen A,Takeichi M,Goridis C,Kincade PW

    更新日期:1989-07-01 00:00:00

  • Transforming genes in human leukemia cells.

    abstract::High-molecular weight DNAs of fresh bone marrow cells from 32 patients with fresh leukemia were assayed for the presence of transmissible activated transforming genes by a DNA-mediated gene transfer technique using NIH/3T3 cells. DNAs of bone marrow cells from four of the 32 patients induced transformation of NIH/3T3 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hirai H,Tanaka S,Azuma M,Anraku Y,Kobayashi Y,Fujisawa M,Okabe T,Urabe A,Takaku F

    更新日期:1985-12-01 00:00:00

  • Paxillin selectively associates with constitutive and chemoattractant-induced high-affinity alpha4beta1 integrins: implications for integrin signaling.

    abstract::Leukocyte alpha4beta1 integrins regulate hematopoietic and lymphoid development, as well as the emigration of circulating cells to sites of inflammation. Because vascular cell adhesion molecule-1 (VCAM-1) binding to high-affinity alpha4beta1 is stable, these integrins can be detected and selectively precipitated from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4402

    authors: Hyduk SJ,Oh J,Xiao H,Chen M,Cybulsky MI

    更新日期:2004-11-01 00:00:00

  • Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.

    abstract::The cell-surface expression of the MIC2 antigen defined by the monoclonal antibody 12E7 was investigated on human leukocytes in bone marrow (BM), thymus, and peripheral blood (PB) using multiparameter flow cytometry and cell sorting. In contrast to preceding reports, we found that the MIC2 antigen is not restricted to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dworzak MN,Fritsch G,Buchinger P,Fleischer C,Printz D,Zellner A,Schöllhammer A,Steiner G,Ambros PF,Gadner H

    更新日期:1994-01-15 00:00:00

  • Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation.

    abstract::We have explored the role of plasminogen activator inhibitor type 2 (PAI-2) in THP-1 monocyte-like cells. These cells possess a mutation in the PAI-2 gene and do not produce an active PAI-2 protein. Transfection of THP-1 cells with plasmids expressing active PAI-2 reduced the cells' inherent adhesive properties and de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.8.2810

    authors: Yu H,Maurer F,Medcalf RL

    更新日期:2002-04-15 00:00:00

  • How I manage ibrutinib-refractory chronic lymphocytic leukemia.

    abstract::The introduction of the Bruton tyrosine kinase (BTK) inhibitor ibrutinib has dramatically changed the management of chronic lymphocytic leukemia (CLL). Although responses have been durable in the majority of patients, relapses do occur, especially in the high-risk patient population. Most relapses occur as the result ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-693598

    authors: Woyach JA

    更新日期:2017-03-09 00:00:00

  • Thirty years of hemophilia treatment in the Netherlands, 1972-2001.

    abstract::Since the introduction of replacement therapy in the early 1960s by the infusion of plasma-derived factor VIII and IX preparations, important changes have occurred for hemophilia patients. We studied the medical and social developments over 30 years of hemophilia treatment. Since 1972, 5 cross-sectional national posta...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-2008

    authors: Plug I,van der Bom JG,Peters M,Mauser-Bunschoten EP,de Goede-Bolder A,Heijnen L,Smit C,Zwart-van Rijkom JE,Willemse J,Rosendaal FR

    更新日期:2004-12-01 00:00:00

  • Thrombopoietin signal transduction in purified murine megakaryocytes.

    abstract::Thrombopoietin (TPO) is a recently cloned cytokine that binds to its receptor, Mpl, and promotes hematopoietic expansion and maturation, primarily of the megakaryocyte lineage. The signaling pathways responsible for these events are thought to involve the Janus family of nonreceptor tyrosine kinases (JAKs) and the sig...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Drachman JG,Sabath DF,Fox NE,Kaushansky K

    更新日期:1997-01-15 00:00:00

  • Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.

    abstract::BMS-354825 (dasatinib) and AMN107 (nilotinib) are potent alternate Abl inhibitors with activity against many imatinib mesylate-resistant BCR-ABL kinase domain (KD) mutants, except T315I. We used N-ethyl-N-nitrosourea (ENU)-exposed Ba/F3-p210(BCR-ABL) cells to compare incidence and types of KD mutants emerging in the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-004580

    authors: Bradeen HA,Eide CA,O'Hare T,Johnson KJ,Willis SG,Lee FY,Druker BJ,Deininger MW

    更新日期:2006-10-01 00:00:00

  • Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

    abstract::Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected f...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-378943

    authors: Pui CH,Mullighan CG,Evans WE,Relling MV

    更新日期:2012-08-09 00:00:00

  • CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.

    abstract::CD10 and MUM1 are representative B cell differentiation markers. Follicular lymphoma (FL) is usually positive for CD10 and negative for MUM1. In this study, however, we compared 22 FLs with peculiar phenotype CD10-MUM1+ with 119 typical CD10+MUM1- FLs. All CD10-MUM1+ FL patients exhibited follicular structure with fol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-045989

    authors: Karube K,Guo Y,Suzumiya J,Sugita Y,Nomura Y,Yamamoto K,Shimizu K,Yoshida S,Komatani H,Takeshita M,Kikuchi M,Nakamura N,Takasu O,Arakawa F,Tagawa H,Seto M,Ohshima K

    更新日期:2007-04-01 00:00:00

  • B-cell development in the thymus is limited by inhibitory signals from the thymic microenvironment.

    abstract::B-cell precursors are present in the thymus, and the thymic microenvironment is the source of lymphopoietic factors that include interleukin-7 (IL-7). Despite the fact that intrathymic B-cell progenitors are bone marrow-derived cells, the data in this report demonstrate that these progenitors accumulate at an early pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0733

    authors: Hashimoto Y,Montecino-Rodriguez E,Leathers H,Stephan RP,Dorshkind K

    更新日期:2002-11-15 00:00:00

  • Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) and polycythemia vera (PV) are characterized by persistent platelet activation. The mechanisms involved in their clearance are poorly characterized. In the present study, we report that leukocytes were actively involved in platelet disposal in 51 patients with ET and 30 with PV, but not ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337337

    authors: Maugeri N,Malato S,Femia EA,Pugliano M,Campana L,Lunghi F,Rovere-Querini P,Lussana F,Podda G,Cattaneo M,Ciceri F,Manfredi AA

    更新日期:2011-09-22 00:00:00

  • Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

    abstract::The human peripheral B-cell compartment displays a large population of immunoglobulin M-positive, immunoglobulin D-positive CD27(+) (IgM(+)IgD(+)CD27(+)) "memory" B cells carrying a mutated immunoglobulin receptor. By means of phenotypic analysis, complementarity-determining region 3 (CDR3) spectratyping during a T-in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0346

    authors: Weller S,Braun MC,Tan BK,Rosenwald A,Cordier C,Conley ME,Plebani A,Kumararatne DS,Bonnet D,Tournilhac O,Tchernia G,Steiniger B,Staudt LM,Casanova JL,Reynaud CA,Weill JC

    更新日期:2004-12-01 00:00:00

  • Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation.

    abstract::Erythropoiesis is regulated at multiple levels to ensure the proper generation of mature red cells under multiple physiological conditions. To probe the contribution of long noncoding RNAs (lncRNAs) to this process, we examined >1 billion RNA-seq reads of polyadenylated and nonpolyadenylated RNA from differentiating m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-530683

    authors: Alvarez-Dominguez JR,Hu W,Yuan B,Shi J,Park SS,Gromatzky AA,van Oudenaarden A,Lodish HF

    更新日期:2014-01-23 00:00:00

  • A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding.

    abstract::Antithrombotic therapies reduce cardiovascular diseases by preventing arterial thrombosis and thromboembolism, but at expense of increased bleeding risks. Arterial thrombosis studies using genetically modified mice have been invaluable for identification of new molecular targets. Because of low sample sizes and hetero...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-02-831982

    authors: Baaten CCFMJ,Meacham S,de Witt SM,Feijge MAH,Adams DJ,Akkerman JN,Cosemans JMEM,Grassi L,Jupe S,Kostadima M,Mattheij NJA,Prins MH,Ramirez-Solis R,Soehnlein O,Swieringa F,Weber C,White JK,Ouwehand WH,Heemskerk JWM

    更新日期:2018-12-13 00:00:00

  • Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1.

    abstract::Recent reports have shown that leukocyte-leukocyte adhesion is dependent on L-selectin and that leukocyte recognition of L-selectin may be mediated by P-selectin glycoprotein ligand-1 (PSGL-1). We show that the specific attachment and rolling of human neutrophils and the leukemia cell lines HL-60 and U937 on immobiliz...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ramos CL,Smith MJ,Snapp KR,Kansas GS,Stickney GW,Ley K,Lawrence MB

    更新日期:1998-02-01 00:00:00

  • Increased calcium permeability of cold-stored erythrocytes.

    abstract::The calcium, sodium, and magnesium permeability of erythrocytes from blood stored at 4 degrees C in various anticoagulant media has been studied and compared to that of fresh erythrocytes. Passive influx of CA2+ was measured at 37 degrees C in cells pretreated to abolish Ca2+ pumping and was up to fivefold greater for...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wiley JS,McCulloch KE,Bowden DS

    更新日期:1982-07-01 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes.

    abstract::The dendritic cell (DC)-specific molecule DC-SIGN is a receptor for the HIV-1 envelope glycoprotein gp120 and is essential for the dissemination of HIV-1. DC-SIGN is expressed by DCs, both monocyte-derived DCs and DCs in several tissues, including mucosa and lymph nodes. To identify a DC-SIGN(+) DC in blood that may b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0179

    authors: Engering A,Van Vliet SJ,Geijtenbeek TB,Van Kooyk Y

    更新日期:2002-09-01 00:00:00